COVID-19 and asthma; What comments we need to know?

Javad Ghaffari, Abbas Dabbaghzadeh, Negar Ghaffari

DOI: 10.22122/cdj.v0i0.517


BACKGROUND: Asthma is a common chronic inflammatory respiratory disease more common in children. Microbial agents such as viruses are a common trigger of asthma. Coronavirus disease 2019 (COVID-19) is a pandemic disease that could lead to the exacerbation of allergic disorders such as asthma. The aim of this study is to write a narrative review of COVID-19 and asthma condition.

METHODS: We searched in Google scholar, PubMed, and Scopus databases with keywords COVID-19, asthma, corticosteroid, and inhaled steroids.

RESULTS: We found a few original articles on the combined subject of asthma and COVID-19. More than 50% of our data is expert comments at valid websites such as or The typical treatment recommended in the exacerbation of asthma or chronic obstructive pulmonary disease (COPD) included the use of corticosteroids. The routine use of corticosteroids in patients with COVID-19 without obstructive lung disease is not advised, as it may prolong viral replication.

CONCLUSION: Patients with asthma need to continue on their preventive asthma medication, such as inhaled corticosteroids (ICS) in pandemic COVID-19.


COVID-19; Asthma; Therapeutics; Steroids

Full Text:



Lupia T, Scabini S, Mornese PS, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist 2020; 21: 22-7.

Ghaffari J, Aarabi M. The prevalence of pediatric asthma in the Islamic Republic of Iran: A review and meta-analysis. J Pediatr Rev 2013; 1(1): 2-11.

Zamanfar D, Gaffari J, Behzadnia S, Yazdani-Charati J, Tavakoli S. The Prevalence of Allergic Rhinitis, Eczema and Asthma in Students of Guidance Schools in Mazandaran Province, Iran. Open Access Maced J Med Sci 2016; 4(4): 619-23.

Ghaffari J, Mohammadzadeh I, Khalilian A, Rafatpanah H, Mohammadjafari H, Davoudi A. Prevalence of asthma, allergic rhinitis and eczema in elementary schools in Sari (Iran). Caspian J Intern Med 2012; 3(1): 372-6.

Ghaffari J, Abbaskhanian A, Jalili M. IQ scores of children with moderate asthma: A comparison with healthy children. Oman Med J 2014; 29(1): 71-4.

Ghaffari J, Hadian A, Daneshpoor S, Khademloo M. Asthma burden in the hospitalized patients in north of Iran. Int J Pediatr 2014; 2(4): 257-66.

Hatami H, Ghaffari N, Ghaffari J, Rafatpanah H. Role of cytokines and chemokines in the outcome of children with severe Asthma. J Pediatr Rev 2019; 7(1): 17-28.

Aghajani M, Rafiei A, Ghaffari J, Valadan R, Kardan M. Immune dysregulation in children with allergic asthma, a close relationship between IL-17 but not IL-4 or IFN-g, and Disease Severity. Res Mol Med 2018; 6(1): 16-29.

Kardan M, Ghaffari J, Valadan R, Rafiei A, Soltani M, Aghajani M, et al. T-bet and GATA-3 Gene Expression in Children with Allergic Asthma and Healthy Controls. J Mazandaran Univ Med Sci 2017; 26(146): 9-21. [In Persian].

Farid Hossaini R, Ghaffari J, Ranjbar A, Haghshenas MR, Rafatpanah H. Infections in children with Asthma. J Pediatr Rev 2013; 1(1): 25-36.

Hartmann-Boyce J, Hobbs R. Inhaled steroids in Asthma during the COVID-19 Outbreak [Online]. [cited 2020]; Available from: URL:

Ghaffari J, Ashrafi H, Ranjbar AR, Nazari Z. Vitamin E in children with asthma: A review. J Pediatr Rev 2014; 2(2): 57-65.

Ghaffari J, Farid Hossiani R, Khalilian A, Nahanmoghadam N, Salehifar E, Rafatpanah H. Vitamin e supplementation, lung functions and clinical manifestations in children with moderate asthma: A randomized double blind placebo- controlled trial. Iran J Allergy Asthma Immunol 2014; 13(2): 98-103.

Global Initiative for Asthma (GINA). 2019 GINA Report, Global Strategy for Asthma Management and Prevention [Online]. [cited 2019]; Available from: URL:

American Academy of Allergy Asthma and Immunology (AAAAI). COVID-19 and Asthma: What patients need to know [Online]. [cited 2020]; Available from: URL:

Hartmann-Boyce J, Hobbs R. Inhaled Steroids in Asthma during the COVID-19 Outbreak [Online]. [cited 2020]; Available from: URL:

Global Initiative for Asthma (GINA). COVID-19: GINA answers to frequently asked questions on asthma management [Online]. [cited 2020]; Available from: URL:

Johnson K. Asthma Patients: Stay on steroids in face of COVID-19, Say Experts [Online]. [cited 2020]; Available from: URL:

Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8(4): 420-2.

Huang Y, Yang R, Xu Y, Gong P. Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China [Online]. [cited 2020]; Available from: URL:

Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15 [Online]. [cited 2020]; Available from: URL:

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020.

Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci 2020; 35(10): e112.

Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, et al. Prevalence, risk factors, and management of asthma in China: A national cross-sectional study. Lancet 2019; 394(10196): 407-18.

Amirav I, Newhouse MT. Transmission of coronavirus by nebulizer: A serious, underappreciated risk. CMAJ 2020; 192(13): E346.

Desai M, Oppenheimer J, Lang DM. Immunomodulators and biologics: Beyond stepped-care therapy. Clin Chest Med 2019; 40(1): 179-92.

Denman S, Ford K, Toolan J, Mistry A, Corps C, Wood P, et al. Home self-administration of omalizumab for chronic spontaneous urticaria. Br J Dermatol 2016; 175(6): 1405-7.

Cowl C. Bending the curve': A pulmonologist's perspective on COVID-19 [Online]. [cited 2020]; Available from: URL:

Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, et al. COVID-19: Pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract 2020.

Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EW. COVID-19: Pandemic Contingency planning for the allergy and immunology clinic [Online]. [cited 2020]; Available from: URL:

American Academy of Allergy Asthma and Immunology (AAAAI). COVID-19 and Asthma [Online]. [cited 2020]; Available from: URL;

Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020; 395(10223): 473-5.

Zhao JP, Hu Y, Du RH, Chen ZS, Jin Y, Zhou M, et al. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43(3): 183-4.

Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020; 87(4): 281-6.

Centers for Disease Control and Prevention.(CDC) Coronavirus (COVID-19) [Online]. [cited 2020]; Available from: URL:


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 4.0

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.